These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 35581935)

  • 21. Heart Failure with Preserved Ejection Fraction-a Concise Review.
    Adamczak DM; Oduah MT; Kiebalo T; Nartowicz S; Bęben M; Pochylski M; Ciepłucha A; Gwizdała A; Lesiak M; Straburzyńska-Migaj E
    Curr Cardiol Rep; 2020 Jul; 22(9):82. PubMed ID: 32648130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heart failure with preserved ejection fraction has a better long-term prognosis than heart failure with reduced ejection fraction in old patients in a 5-year follow-up retrospective study.
    Kontogeorgos S; Thunström E; Johansson MC; Fu M
    Int J Cardiol; 2017 Apr; 232():86-92. PubMed ID: 28100428
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic clustering of heart failure with preserved ejection fraction reveals different rates of hospitalization.
    Casebeer A; Horter L; Hayden J; Simmons J; Evers T
    J Cardiovasc Med (Hagerstown); 2021 Jan; 22(1):45-52. PubMed ID: 32941326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The future of heart failure with preserved ejection fraction : Deep phenotyping for targeted therapeutics.
    Heinzel FR; Shah SJ
    Herz; 2022 Aug; 47(4):308-323. PubMed ID: 35767073
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of the frontal QRS-T angle with adverse cardiac remodeling, impaired left and right ventricular function, and worse outcomes in heart failure with preserved ejection fraction.
    Selvaraj S; Ilkhanoff L; Burke MA; Freed BH; Lang RM; Martinez EE; Shah SJ
    J Am Soc Echocardiogr; 2014 Jan; 27(1):74-82.e2. PubMed ID: 24075945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying Phenogroups in patients with subclinical diastolic dysfunction using unsupervised statistical learning.
    Kaptein YE; Karagodin I; Zuo H; Lu Y; Zhang J; Kaptein JS; Strande JL
    BMC Cardiovasc Disord; 2020 Aug; 20(1):367. PubMed ID: 32795252
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence Supporting the Existence of a Distinct Obese Phenotype of Heart Failure With Preserved Ejection Fraction.
    Obokata M; Reddy YNV; Pislaru SV; Melenovsky V; Borlaug BA
    Circulation; 2017 Jul; 136(1):6-19. PubMed ID: 28381470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heart Failure with Preserved Ejection Fraction: Mechanisms and Treatment Strategies.
    Omote K; Verbrugge FH; Borlaug BA
    Annu Rev Med; 2022 Jan; 73():321-337. PubMed ID: 34379445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Relevance of Left Atrial Dysfunction in Heart Failure With Preserved Ejection Fraction.
    Santos AB; Roca GQ; Claggett B; Sweitzer NK; Shah SJ; Anand IS; Fang JC; Zile MR; Pitt B; Solomon SD; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002763. PubMed ID: 27056882
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heart Failure and Midrange Ejection Fraction: Implications of Recovered Ejection Fraction for Exercise Tolerance and Outcomes.
    Nadruz W; West E; Santos M; Skali H; Groarke JD; Forman DE; Shah AM
    Circ Heart Fail; 2016 Apr; 9(4):e002826. PubMed ID: 27009553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response.
    Kao DP; Lewsey JD; Anand IS; Massie BM; Zile MR; Carson PE; McKelvie RS; Komajda M; McMurray JJ; Lindenfeld J
    Eur J Heart Fail; 2015 Sep; 17(9):925-35. PubMed ID: 26250359
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of distinct phenotypic clusters in heart failure with preserved ejection fraction.
    Uijl A; Savarese G; Vaartjes I; Dahlström U; Brugts JJ; Linssen GCM; van Empel V; Brunner-La Rocca HP; Asselbergs FW; Lund LH; Hoes AW; Koudstaal S
    Eur J Heart Fail; 2021 Jun; 23(6):973-982. PubMed ID: 33779119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pilot study for left ventricular imaging phenotype of patients over 65 years old with heart failure and preserved ejection fraction: the high prevalence of amyloid cardiomyopathy.
    Bennani Smires Y; Victor G; Ribes D; Berry M; Cognet T; Méjean S; Huart A; Roussel M; Petermann A; Roncalli J; Carrié D; Rousseau H; Berry I; Chauveau D; Galinier M; Lairez O
    Int J Cardiovasc Imaging; 2016 Sep; 32(9):1403-1413. PubMed ID: 27240600
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular features of heart failure with preserved ejection fraction versus nonfailing hypertensive left ventricular hypertrophy in the urban Baltimore community: the role of atrial remodeling/dysfunction.
    Melenovsky V; Borlaug BA; Rosen B; Hay I; Ferruci L; Morell CH; Lakatta EG; Najjar SS; Kass DA
    J Am Coll Cardiol; 2007 Jan; 49(2):198-207. PubMed ID: 17222731
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early Identification of Patients at Risk for Incident Heart Failure With Preserved Ejection Fraction: Novel Approach to Echocardiographic Trends.
    Lekavich CL; Abraham D; Fudim M; Green C; Mentz RJ; Harshaw-Ellis K; Bowers M; Kelsey A; Parikh K; Truong T; Barksdale D; Kraus WE
    J Card Fail; 2021 Sep; 27(9):942-948. PubMed ID: 33965536
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the adverse outcome of subtypes of heart failure with preserved ejection fraction defined by machine learning: A systematic review focused on defining high risk phenogroups.
    Rabkin SW
    EXCLI J; 2022; 21():487-518. PubMed ID: 35391918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction.
    Kanagala P; Cheng ASH; Singh A; Khan JN; Gulsin GS; Patel P; Gupta P; Arnold JR; Squire IB; Ng LL; McCann GP
    JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 2):2291-2301. PubMed ID: 30772227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics and Clinical Outcomes in Patients With Heart Failure With Preserved Ejection Fraction Compared to Heart Failure With Reduced Ejection Fraction: Insights From the VCOR Heart Failure Snapshot.
    Tan C; Dinh D; Brennan A; Hare DL; Kaye D; Lefkovits J; Lockwood S; Neil C; Prior D; Nasis A; Wilson A; Reid CM; Stub D; Driscoll A
    Heart Lung Circ; 2022 May; 31(5):623-628. PubMed ID: 34742643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics and Outcomes of Adult Outpatients With Heart Failure and Improved or Recovered Ejection Fraction.
    Kalogeropoulos AP; Fonarow GC; Georgiopoulou V; Burkman G; Siwamogsatham S; Patel A; Li S; Papadimitriou L; Butler J
    JAMA Cardiol; 2016 Aug; 1(5):510-8. PubMed ID: 27434402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.